Compounds > 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline
Page last updated: 2024-10-29

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Thromboembolism

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline has been researched along with Thromboembolism in 1 studies

WHI P131: a quinazoline derivative, inhibitor of glioblastoma cell adhesion and migration

Thromboembolism: Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Uckun, FM1
Vassilev, A1
Bartell, S1
Zheng, Y1
Mahajan, S1
Tibbles, HE1

Other Studies

1 other study available for 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Thromboembolism

ArticleYear
The anti-leukemic Bruton's tyrosine kinase inhibitor alpha-cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl) propenamide (LFM-A13) prevents fatal thromboembolism.
    Leukemia & lymphoma, 2003, Volume: 44, Issue:9

    Topics: Adenosine Diphosphate; Agammaglobulinaemia Tyrosine Kinase; Amides; Animals; Aspirin; Bleeding Time;

2003